Publication:
Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab

cris.virtualsource.author-orcid5e361008-b274-4679-8b1f-32b47a440de6
cris.virtualsource.author-orcid47b676b5-10bd-410c-9424-b51de514bd1b
datacite.rightsopen.access
dc.contributor.authorHelbling, Daniel
dc.contributor.authorBorner, Markus
dc.date.accessioned2024-10-13T17:20:08Z
dc.date.available2024-10-13T17:20:08Z
dc.date.issued2007
dc.description.numberOfPages2
dc.description.sponsorshipUniversitätsklinik für Medizinische Onkologie
dc.identifier.doi10.7892/boris.22397
dc.identifier.isi000247241200027
dc.identifier.pmid17488734
dc.identifier.publisherDOI10.1093/annonc/mdm130
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/96084
dc.language.isoen
dc.publisherOxford University Press
dc.publisher.placeOxford
dc.relation.isbn17488734
dc.relation.ispartofAnnals of oncology
dc.relation.issn0923-7534
dc.relation.organizationClinic of Medical Oncology
dc.titleSuccessful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage4
oaire.citation.issue5
oaire.citation.startPage963
oaire.citation.volume18
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2019-10-27 22:04:46
unibe.description.ispublishedpub
unibe.eprints.legacyId22397
unibe.journal.abbrevTitleANN ONCOL
unibe.refereedtrue
unibe.subtype.articlecontribution

Files

Original bundle
Now showing 1 - 1 of 1
Name:
mdm130.pdf
Size:
33.99 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections